Nevada Rx PSE bill dies
This article was originally published in The Tan Sheet
Executive Summary
Nevada state legislators May 22 rejected a proposal to require pseudoephedrine-containing products to be sold only by prescription. The bill, AB 150, did not receive the necessary two-thirds majority to pass. The Consumer Healthcare Products Association lobbied against the bill after its introduction (1"The Tan Sheet" Feb. 26, 2007, In Brief). Currently, Oklahoma and Oregon each have a state law requring prescription-only access to pseudoephedrine products (2"The Tan Sheet" April 12, 2004, p. 4 and 3"The Tan Sheet" Aug. 22, 2005, p. 5)...
|
Nevada state legislators May 22 rejected a proposal to require pseudoephedrine-containing products to be sold only by prescription. The bill, AB 150, did not receive the necessary two-thirds majority to pass. The Consumer Healthcare Products Association lobbied against the bill after its introduction (1 'The Tan Sheet' Feb. 26, 2007, In Brief). Currently, Oklahoma and Oregon each have a state law requring prescription-only access to pseudoephedrine products (2 (Also see "Pseudoephedrine Tablets Go Behind The Counter In Oklahoma" - Pink Sheet, 12 Apr, 2004.), p. 4 and 3 (Also see "Oregon Pseudoephedrine Law Requires Prescription Status By July 2006" - Pink Sheet, 22 Aug, 2005.), p. 5).... |